Logo image of CPRT

COPART INC (CPRT) Stock Fundamental Analysis

USA - NASDAQ:CPRT - US2172041061 - Common Stock

44.34 USD
+0.29 (+0.65%)
Last: 10/17/2025, 8:04:07 PM
44.23 USD
-0.11 (-0.25%)
After Hours: 10/17/2025, 8:04:07 PM
Fundamental Rating

7

Overall CPRT gets a fundamental rating of 7 out of 10. We evaluated CPRT against 84 industry peers in the Commercial Services & Supplies industry. CPRT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CPRT is valied quite expensively at the moment, while it does show a decent growth rate. This makes CPRT very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CPRT had positive earnings in the past year.
CPRT had a positive operating cash flow in the past year.
CPRT had positive earnings in each of the past 5 years.
CPRT had a positive operating cash flow in each of the past 5 years.
CPRT Yearly Net Income VS EBIT VS OCF VS FCFCPRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

CPRT has a Return On Assets of 15.38%. This is amongst the best in the industry. CPRT outperforms 96.43% of its industry peers.
CPRT has a Return On Equity of 16.90%. This is amongst the best in the industry. CPRT outperforms 82.14% of its industry peers.
CPRT has a Return On Invested Capital of 14.53%. This is amongst the best in the industry. CPRT outperforms 90.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPRT is significantly above the industry average of 10.17%.
Industry RankSector Rank
ROA 15.38%
ROE 16.9%
ROIC 14.53%
ROA(3y)16.64%
ROA(5y)18.2%
ROE(3y)18.56%
ROE(5y)21.16%
ROIC(3y)16.65%
ROIC(5y)18.96%
CPRT Yearly ROA, ROE, ROICCPRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 33.41%, CPRT belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
CPRT's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 36.51%, CPRT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPRT has remained more or less at the same level.
CPRT has a better Gross Margin (45.18%) than 82.14% of its industry peers.
In the last couple of years the Gross Margin of CPRT has remained more or less at the same level.
Industry RankSector Rank
OM 36.51%
PM (TTM) 33.41%
GM 45.18%
OM growth 3Y-2.4%
OM growth 5Y-0.27%
PM growth 3Y2.37%
PM growth 5Y1.03%
GM growth 3Y-0.82%
GM growth 5Y-0.38%
CPRT Yearly Profit, Operating, Gross MarginsCPRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

CPRT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CPRT has been increased compared to 1 year ago.
Compared to 5 years ago, CPRT has more shares outstanding
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPRT Yearly Shares OutstandingCPRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
CPRT Yearly Total Debt VS Total AssetsCPRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 31.04 indicates that CPRT is not in any danger for bankruptcy at the moment.
CPRT has a Altman-Z score of 31.04. This is amongst the best in the industry. CPRT outperforms 96.43% of its industry peers.
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 31.04
ROIC/WACC1.68
WACC8.66%
CPRT Yearly LT Debt VS Equity VS FCFCPRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

CPRT has a Current Ratio of 8.42. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.42, CPRT belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
A Quick Ratio of 8.36 indicates that CPRT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 8.36, CPRT belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.42
Quick Ratio 8.36
CPRT Yearly Current Assets VS Current LiabilitesCPRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

CPRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.11%, which is quite good.
CPRT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.48% yearly.
Looking at the last year, CPRT shows a quite strong growth in Revenue. The Revenue has grown by 9.68% in the last year.
The Revenue has been growing by 16.07% on average over the past years. This is quite good.
EPS 1Y (TTM)15.11%
EPS 3Y4.93%
EPS 5Y4.48%
EPS Q2Q%24.24%
Revenue 1Y (TTM)9.68%
Revenue growth 3Y9.9%
Revenue growth 5Y16.07%
Sales Q2Q%5.25%

3.2 Future

CPRT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.22% yearly.
The Revenue is expected to grow by 10.74% on average over the next years. This is quite good.
EPS Next Y8.66%
EPS Next 2Y9.68%
EPS Next 3Y11.68%
EPS Next 5Y11.22%
Revenue Next Year4.87%
Revenue Next 2Y6.27%
Revenue Next 3Y10.91%
Revenue Next 5Y10.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CPRT Yearly Revenue VS EstimatesCPRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
CPRT Yearly EPS VS EstimatesCPRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.71, which means the current valuation is very expensive for CPRT.
CPRT's Price/Earnings is on the same level as the industry average.
CPRT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.40.
CPRT is valuated quite expensively with a Price/Forward Earnings ratio of 25.50.
CPRT's Price/Forward Earnings ratio is in line with the industry average.
CPRT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 27.71
Fwd PE 25.5
CPRT Price Earnings VS Forward Price EarningsCPRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CPRT's Enterprise Value to EBITDA ratio is in line with the industry average.
CPRT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.86
EV/EBITDA 18.72
CPRT Per share dataCPRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CPRT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.2
PEG (5Y)6.18
EPS Next 2Y9.68%
EPS Next 3Y11.68%

0

5. Dividend

5.1 Amount

No dividends for CPRT!.
Industry RankSector Rank
Dividend Yield N/A

COPART INC

NASDAQ:CPRT (10/17/2025, 8:04:07 PM)

After market: 44.23 -0.11 (-0.25%)

44.34

+0.29 (+0.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)11-19 2025-11-19
Inst Owners86.57%
Inst Owner Change0.04%
Ins Owners8.65%
Ins Owner Change0.68%
Market Cap42.91B
Analysts78.89
Price Target58.79 (32.59%)
Short Float %2.97%
Short Ratio3.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.11%
Min EPS beat(2)-1.18%
Max EPS beat(2)11.39%
EPS beat(4)2
Avg EPS beat(4)3.73%
Min EPS beat(4)-1.18%
Max EPS beat(4)11.39%
EPS beat(8)3
Avg EPS beat(8)-0.12%
EPS beat(12)6
Avg EPS beat(12)0.43%
EPS beat(16)10
Avg EPS beat(16)0.67%
Revenue beat(2)0
Avg Revenue beat(2)-3.07%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-2.84%
Revenue beat(4)2
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)2.21%
Revenue beat(8)4
Avg Revenue beat(8)-0.99%
Revenue beat(12)6
Avg Revenue beat(12)-0.71%
Revenue beat(16)9
Avg Revenue beat(16)0.47%
PT rev (1m)-2.67%
PT rev (3m)-7.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.77%
EPS NY rev (1m)-1.36%
EPS NY rev (3m)-1.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.66%
Valuation
Industry RankSector Rank
PE 27.71
Fwd PE 25.5
P/S 9.23
P/FCF 34.86
P/OCF 23.84
P/B 4.67
P/tB 4.99
EV/EBITDA 18.72
EPS(TTM)1.6
EY3.61%
EPS(NY)1.74
Fwd EY3.92%
FCF(TTM)1.27
FCFY2.87%
OCF(TTM)1.86
OCFY4.19%
SpS4.8
BVpS9.49
TBVpS8.89
PEG (NY)3.2
PEG (5Y)6.18
Profitability
Industry RankSector Rank
ROA 15.38%
ROE 16.9%
ROCE 18.04%
ROIC 14.53%
ROICexc 29.6%
ROICexgc 33.85%
OM 36.51%
PM (TTM) 33.41%
GM 45.18%
FCFM 26.49%
ROA(3y)16.64%
ROA(5y)18.2%
ROE(3y)18.56%
ROE(5y)21.16%
ROIC(3y)16.65%
ROIC(5y)18.96%
ROICexc(3y)29.8%
ROICexc(5y)30.16%
ROICexgc(3y)49.81%
ROICexgc(5y)44.01%
ROCE(3y)20.67%
ROCE(5y)23.54%
ROICexcg growth 3Y-2.56%
ROICexcg growth 5Y2.8%
ROICexc growth 3Y-2.36%
ROICexc growth 5Y3.37%
OM growth 3Y-2.4%
OM growth 5Y-0.27%
PM growth 3Y2.37%
PM growth 5Y1.03%
GM growth 3Y-0.82%
GM growth 5Y-0.38%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 261.26%
Cap/Sales 12.24%
Interest Coverage 840.37
Cash Conversion 94.01%
Profit Quality 79.28%
Current Ratio 8.42
Quick Ratio 8.36
Altman-Z 31.04
F-Score6
WACC8.66%
ROIC/WACC1.68
Cap/Depr(3y)284.46%
Cap/Depr(5y)294.6%
Cap/Sales(3y)12.55%
Cap/Sales(5y)12.9%
Profit Quality(3y)72.77%
Profit Quality(5y)70.33%
High Growth Momentum
Growth
EPS 1Y (TTM)15.11%
EPS 3Y4.93%
EPS 5Y4.48%
EPS Q2Q%24.24%
EPS Next Y8.66%
EPS Next 2Y9.68%
EPS Next 3Y11.68%
EPS Next 5Y11.22%
Revenue 1Y (TTM)9.68%
Revenue growth 3Y9.9%
Revenue growth 5Y16.07%
Sales Q2Q%5.25%
Revenue Next Year4.87%
Revenue Next 2Y6.27%
Revenue Next 3Y10.91%
Revenue Next 5Y10.74%
EBIT growth 1Y7.93%
EBIT growth 3Y7.26%
EBIT growth 5Y15.76%
EBIT Next Year24.88%
EBIT Next 3Y17.67%
EBIT Next 5Y16.74%
FCF growth 1Y27.99%
FCF growth 3Y13.61%
FCF growth 5Y30.44%
OCF growth 1Y22.22%
OCF growth 3Y15.22%
OCF growth 5Y14.42%